BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 27927187)

  • 1. The importance of proteinuria and prior cardiovascular disease in all major clinical outcomes of atherosclerotic renovascular disease - a single-center observational study.
    Vassallo D; Ritchie J; Green D; Chrysochou C; Blunt J; Kalra PA
    BMC Nephrol; 2016 Dec; 17(1):198. PubMed ID: 27927187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of revascularization in patients with anatomically significant atherosclerotic renovascular disease presenting with high-risk clinical features.
    Vassallo D; Ritchie J; Green D; Chrysochou C; Kalra PA
    Nephrol Dial Transplant; 2018 Mar; 33(3):497-506. PubMed ID: 28371854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization.
    Ritchie J; Green D; Chrysochou C; Chalmers N; Foley RN; Kalra PA
    Am J Kidney Dis; 2014 Feb; 63(2):186-97. PubMed ID: 24074824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a clinical risk calculator for major clinical outcomes in patients with atherosclerotic renovascular disease.
    Vassallo D; Foley RN; Kalra PA
    Nephrol Dial Transplant; 2019 Aug; 34(8):1377-1384. PubMed ID: 29939316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular disease.
    Ritchie J; Green D; Alderson HV; Chrysochou C; Vassallo D; Sinha S; Kalra PA
    J Am Soc Hypertens; 2016 Feb; 10(2):149-158.e3. PubMed ID: 26778771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
    Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate.
    Qiao Y; Shin JI; Chen TK; Inker LA; Coresh J; Alexander GC; Jackson JW; Chang AR; Grams ME
    JAMA Intern Med; 2020 May; 180(5):718-726. PubMed ID: 32150237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease.
    Misra S; Khosla A; Allred J; Harmsen WS; Textor SC; McKusick MA
    J Vasc Interv Radiol; 2016 Aug; 27(8):1215-24. PubMed ID: 27296703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
    Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
    J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
    Chen DC; Singh GD; Armstrong EJ; Waldo SW; Laird JR; Amsterdam EA
    Am J Cardiol; 2017 Apr; 119(8):1146-1152. PubMed ID: 28259239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis.
    Kalra PA; Guo H; Kausz AT; Gilbertson DT; Liu J; Chen SC; Ishani A; Collins AJ; Foley RN
    Kidney Int; 2005 Jul; 68(1):293-301. PubMed ID: 15954920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
    Ezekowitz J; McAlister FA; Humphries KH; Norris CM; Tonelli M; Ghali WA; Knudtson ML;
    J Am Coll Cardiol; 2004 Oct; 44(8):1587-92. PubMed ID: 15489090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease.
    Chrysochou C; Foley RN; Young JF; Khavandi K; Cheung CM; Kalra PA
    Nephrol Dial Transplant; 2012 Apr; 27(4):1403-9. PubMed ID: 21993376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition.
    Losito A; Errico R; Santirosi P; Lupattelli T; Scalera GB; Lupattelli L
    Nephrol Dial Transplant; 2005 Aug; 20(8):1604-9. PubMed ID: 15870215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of cardiac dysfunction in patients with atherosclerotic renovascular disease.
    Wright JR; Shurrab AE; Cooper A; Kalra PR; Foley RN; Kalra PA
    QJM; 2009 Oct; 102(10):695-704. PubMed ID: 19667039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease.
    Ho PM; Magid DJ; Shetterly SM; Olson KL; Maddox TM; Peterson PN; Masoudi FA; Rumsfeld JS
    Am Heart J; 2008 Apr; 155(4):772-9. PubMed ID: 18371492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease.
    Wright JR; Shurrab AE; Cheung C; Waldek S; O'Donoghue DJ; Foley RN; Mamtora H; Kalra PA
    Am J Kidney Dis; 2002 Jun; 39(6):1153-61. PubMed ID: 12046025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes.
    Fu EL; Trevisan M; Clase CM; Evans M; Lindholm B; Rotmans JI; van Diepen M; Dekker FW; Carrero JJ
    Clin J Am Soc Nephrol; 2019 Sep; 14(9):1336-1345. PubMed ID: 31395593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
    Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
    BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.